Key Takeaways
- H1 revenue surged 26% YoY on deliberate execution smoothing and preponed deliveries, not a one-off Q4 push; management held its full-year 15–20% growth guide and flagged possible upside.
- QRSAM is the make-or-break number: the ₹30,000 cr order is “more than 99%” certain to land before year-end, and BEL has already started pre-work to compress the timeline, so the slip from March is framed as a few months’ delay, not a loss.
- The AMCA bid is in, and management sounds unusually bullish: submitted as a 50-50 consortium with L&T, described as “very, very competitive,” with a stated hope of being L1 after a 2–3 month technical evaluation.
- Margins are holding steady across nomination and competitive orders alike, management insists, because nomination status was earned through L1 wins and is retained on product uniqueness, not favoritism.
- What to watch next quarter: whether QRSAM actually clears CCS, whether NGC line items start converting to POs before March, and whether the AMCA technical evaluation opens the price bid before year-end.
The QRSAM Overhang
- Order confidence is near-absolute: management pegs the probability at “more than 99%” and expects the order “very shortly,” hopefully in the next CCS clearance; the value is ~₹30,000 cr.
- The delay is framed as procedural, not existential: by January–February, management knew document complexity could push the order beyond March; the minimum expectation was August–September, so the current slip is not considered large.
- Pre-work is the hedge: BEL has proactively started QT and First of Production Model (FOPM) realization activities, and supply chain partners (public sector, L&T, 200-plus MSMEs) are investing on their own side to achieve FOPM ahead of time, which management expects will “squeeze a few months” from execution once the order lands.
- Escalation is a known headwind: typically, 1–1.5 years of escalation is not given in government processes; management noted “maybe barring if we are lucky, maybe some 6 months escalation” could be granted.
- The private-sector question was deflected: when asked what share of the ₹30,000 cr QRSAM order could be opened to private players, management said the question should go to BDL, since BEL is not manufacturing QRSAM missiles currently.
Manoj Jain: “I don't think at this point, that private thing is possible. Technically, may not be definitely, because it is a period of 10 to 12 years of cumulative experience of this type of complex system of system, which we have developed over a period of time.”
Order Inflow: The ₹55,000 cr Bridge
- The base case is ₹25,000 cr excluding QRSAM: management is “fully confident” of meeting or exceeding this, with NGC subsystem orders from GSL and GRSE expected imminently (“even tomorrow”) and all line items targeted before March 2027, though 1–2 may slip.
- The upside case is ₹55,000 cr including QRSAM: if QRSAM lands, the number jumps; even without it, other orders in hand are expected to ensure crossing ₹25,000 cr.
- NGC is the largest non-QRSAM piece: total value ~₹20,000 cr, with different line items converting to POs over “1 day to 6 months”; discussions with GSL and GRSE are ongoing and “good homework is done.”
- Three more programs are in the pipeline before March: Shatrughat and Samaghat orders expected “one by one,” and HAMMER “hopefully before March”; files have moved “considerably well.”
- P-75I is the wildcard: management is “not fully sure” it clears this year; if it does, it would be a “pleasant surprise.”
Execution & Revenue Trajectory
- The 26% H1 growth was engineered, not accidental: management deliberately corrected for the historical Q4 loading pattern by working with supply chain partners to make quarterly output more uniform, improving on-time delivery scores, and preponing deliveries by 1–2 months.
- The full-year guide is 15–20% (more than 15%): management is “planning as of now between 15% to 20%” and working to meet all start-of-year guidance parameters; if more comes, “it will be a positive surprise.”
- QRSAM execution is expected to be faster than user expectations: the few months’ delay in acquiring the order “will not translate into execution delay”; management expects to be “even faster than the expectations of users.”
- NGC execution is pegged at 3–4 years maximum after order receipt, depending on ship construction plans of GRSE and GSL; BEL has no production challenges and can prepone supply if required.
- Beyond FY27 color is deferred: management will provide more quantification for the next 3 years in the April concall.
Manoj Jain: “We wanted to correct ourselves to give more uniform output across each quarter. So that correction also we wanted to do instead of loading ourselves in the last quarter and then having suspenses for all of you also.”
AMCA, Missiles & the Next-Gen Portfolio
- AMCA bid submitted in a 50-50 consortium with L&T: L&T is front-ending; management describes the bid as “very, very competitive” and is “hopeful to be L1 after technical evaluation.”
- Technical evaluation may take 2–3 months: price bid could open “hopefully before March”; management expects a “positive surprise.”
- Missile electronics is the structural growth story: 60–70% of a missile’s cost is electronics, and BEL is the formal DCPP partner for DRDO on LRLACM and Pralay missiles, with orders expected in future; the company is also involving with design agencies for 3–4 more strategic missile programs.
- QRSAM is expected to have multiple series orders over time, similar to the Akash system history, with technology refreshes every 3–5 years.
- Seeker business is being positioned for scale: if the missile business is estimated at x, seeker business will be 0.2–0.3x; current combined IR and RF capacity of 1,000-plus can scale 2–3x, with infrastructure-wise no bottleneck.
- Virupaksha radar production orders are still years out: currently executing development order only; production orders expected “maybe around ’28, ’29,” with overall timelines decided by LRDE.
Manoj Jain: “Missiles, you may be knowing, actually 60% to 70% of missile is electronics. The cost of missile, 60% to 70% goes in missile electronics. Remaining only goes into other 2 major components. So the biggest component, I should say, of missiles is electronics and where we have proved our strengths now.”
Drones, Counter-Drones & Emerging Bets
- Drone and counter-drone is the second-most focused area after missiles and ammunition: BEL is working with 6–8 start-ups to make their technologies more robust and has started bidding; small orders of ₹50–100 cr received this year, which management considers too small to discuss on investor calls.
- Management expects at least 1–2 big drone orders next year based on 6–8 big leads and start-up tie-ups, and is confident this will yield “very good business in years to come.”
- Counter-drone systems are already a proven export platform: BEL has established itself over 3–4 years as a reliable supplier of high-end counter-drone systems with hard-kill options; successful demonstrations conducted for foreign countries, and management is “hopeful of getting good export orders very soon.”
- Directed energy weapons (DEW) are the next layer: BEL is developing both microwave-based and laser-based DEWs, pursuing three parallel approaches (DRDO support, in-house R&D, start-up collaboration), and is confident “some good solutions will be immediately offered to customers.”
- HAPS is being approached cautiously: management’s assessment is that HAPS is “still maturing, not a mature product”; BEL is in the process of selecting a partner carefully to minimize development risks and maximize winning probability.
- EW systems demand is “ever increasing” due to hostile environments and fast technology changes; for the last 5 years, all programs being developed have AI and networkable features as basic requirements.
Manoj Jain: “After our missile, arms and ammunition, the second most focused area for us is drone and counter drone. And we may give you a very good pleasant surprise during R&D also, we may launch a few products at that time. Let me assure you.”
Margins, Competition & the Nomination Question
- Management flatly rejects the idea that nomination orders carry higher margins: “whether it is nomination or competition, more or less similar margins will be there.”
- Nomination status was earned through competition: every nomination order today started with multi-vendor competition where BEL became L1; nomination is retained due to uniqueness of products, indigenization content, and customized solutions developed over time, not favoritism.
- FY27 EBITDA margin guidance is ~28% and management is confident of meeting all guidance parameters given at the start of the year.
- R&D spend is guided at ₹2,200-plus cr and capex at ~₹1,200 cr; the defense-to-nondefense mix is expected at 90:10.
Manoj Jain: “Whatsoever nomination you see today, it was actually started with multi-vendor competition, and we became L1. Then only when the product was good for the next ship or next order, they go for BNE buyer nominated or nomination happens. So hardly any nomination on this domain has happened because of other reasons.”
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| FY27 revenue growth | 15–20% (more than 15%); possible positive surprises | FY27 full year |
| FY27 order inflow (ex-QRSAM) | ₹25,000 cr minimum; confident of meeting or exceeding | Before March 2027 |
| FY27 order inflow (incl. QRSAM) | ₹55,000 cr; conditional on QRSAM clearing CCS | Before March 2027 |
| QRSAM order receipt | “Very shortly,” next CCS clearance; “more than 99%” confidence | Before FY27 close |
| NGC subsystem orders | All line items from GSL/GRSE; 1–2 may slip | Before March 2027 |
| Shatrughat, Samaghat, HAMMER orders | All three expected one by one | Before March 2027 |
| AMCA technical evaluation outcome | 2–3 months for evaluation; price bid “hopefully before March” | Possibly Q4 FY27 |
| FY27 EBITDA margin | ~28% | FY27 full year |
| FY27 R&D spend | ₹2,200-plus cr | FY27 full year |
| FY27 capex | ~₹1,200 cr | FY27 full year |
| Beyond-FY27 execution color | Quantification for next 3 years | April concall |
Key Metrics
| Metric | Q2 FY27 |
|---|---|
| H1 FY27 revenue from operations | ₹12,824 cr, +25.97% YoY |
| H1 FY27 profit before tax | ₹3,467 cr, +14.66% YoY |
| H1 FY27 profit after tax | ₹2,589 cr, +14.80% YoY |
| H1 FY27 EBITDA margin | 27.43% |
| H1 FY27 earnings per share | ₹3.54, vs ₹3.09 in H1 FY26 |
| Order book as on 01/10/2026 | ₹68,717 cr |
| Orders acquired in FY27 till 01/10/2026 | ₹7,334 cr |
| FY27 revenue growth guidance | 15% to 20% (more than 15%) |
| FY27 EBITDA margin guidance | ~28% |
| FY27 order inflow guidance (excl. QRSAM) | ₹25,000 cr minimum |
| FY27 order inflow guidance (incl. QRSAM) | ₹50,000+ cr |
| FY27 R&D investment guidance | ₹2,200+ cr |
| FY27 capex guidance | ~₹1,200 cr |
| Defense to non-defense business mix guidance | 90:10 |
| NGC expected order value for BEL | ~₹20,000 cr, electronics portion including MFStar radar, communication, EW, radars; execution over 3–4+ years |
| QRSAM expected order value | ₹30,000 cr (per an analyst's math) |
| Cybersecurity civilian domain orders under execution | ₹400–500 cr worth, with pipeline of thousands of crores |
| Seeker manufacturing capacity | 1,000+ per year combined IR and RF, scalable 2–3x |